SE371745B - - Google Patents
Info
- Publication number
- SE371745B SE371745B SE7005153A SE515370A SE371745B SE 371745 B SE371745 B SE 371745B SE 7005153 A SE7005153 A SE 7005153A SE 515370 A SE515370 A SE 515370A SE 371745 B SE371745 B SE 371745B
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/843—Digestive system
- Y10S530/845—Pancreas
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88256369A | 1969-12-05 | 1969-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE371745B true SE371745B (nl) | 1974-12-02 |
Family
ID=25380854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7005153A SE371745B (nl) | 1969-12-05 | 1970-04-15 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3719655A (nl) |
| CA (1) | CA918565A (nl) |
| DE (1) | DE2018588A1 (nl) |
| DK (1) | DK127165B (nl) |
| FR (1) | FR2045435A5 (nl) |
| GB (1) | GB1269185A (nl) |
| NL (1) | NL154423B (nl) |
| SE (1) | SE371745B (nl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3856771A (en) * | 1973-07-16 | 1974-12-24 | Lilly Co Eli | Process for manufacturing alkali metal or ammonium insulin |
| DE2505308A1 (de) * | 1975-02-07 | 1976-08-19 | Lilly Co Eli | Verfahren zur gewinnung von glucagon |
| EP0102976A1 (en) * | 1982-03-03 | 1984-03-21 | Nordisk Insulinlaboratorium | A process for producing an insulin preparation |
| DE3327709A1 (de) * | 1983-07-29 | 1985-02-07 | Hoechst Ag, 6230 Frankfurt | Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung |
| US5504188A (en) * | 1994-06-16 | 1996-04-02 | Eli Lilly And Company | Preparation of stable zinc insulin analog crystals |
| US5597893A (en) * | 1994-10-31 | 1997-01-28 | Eli Lilly And Company | Preparation of stable insulin analog crystals |
| US6310038B1 (en) * | 1997-03-20 | 2001-10-30 | Novo Nordisk A/S | Pulmonary insulin crystals |
| ATE321783T1 (de) * | 1997-03-20 | 2006-04-15 | Novo Nordisk As | Zinkfreie insulinkristalle für die verwendung in medikamenten, die über die lunge verabreicht werden. |
| US7741281B2 (en) * | 2005-11-03 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7714025B2 (en) * | 2006-05-10 | 2010-05-11 | Arizona Biomedical Research Commission | Modified chalcone compounds as antimitotic agents |
| EP2049149B1 (en) * | 2006-07-31 | 2015-04-15 | Novo Nordisk A/S | Pegylated extended insulins |
| HUE029512T2 (en) * | 2006-09-22 | 2017-03-28 | Novo Nordisk As | Protease Resistant Insulin Analogs |
| JP5496082B2 (ja) * | 2007-04-30 | 2014-05-21 | ノボ・ノルデイスク・エー／エス | タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物 |
| WO2009112583A2 (en) * | 2008-03-14 | 2009-09-17 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
| WO2009115469A1 (en) | 2008-03-18 | 2009-09-24 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
| CN102219851B (zh) * | 2011-05-09 | 2012-05-30 | 甘李药业有限公司 | 甘精胰岛素结晶的制备方法 |
| CA2870313A1 (en) | 2012-04-11 | 2013-10-17 | Novo Nordisk A/S | Insulin formulations |
| WO2015052088A1 (en) | 2013-10-07 | 2015-04-16 | Novo Nordisk A/S | Novel derivative of an insulin analogue |
| EP3185887B1 (en) | 2014-08-26 | 2021-03-10 | Merck Sharp & Dohme Corp. | Method for preparing crystalline insulin or insulin analog compositions |
| HRP20221324T1 (hr) | 2016-12-16 | 2022-12-23 | Novo Nordisk A/S | Farmaceutski pripravci koji sadrže inzulin |
-
1969
- 1969-12-05 US US00882563A patent/US3719655A/en not_active Expired - Lifetime
-
1970
- 1970-03-20 CA CA077988A patent/CA918565A/en not_active Expired
- 1970-04-13 NL NL707005291A patent/NL154423B/nl not_active IP Right Cessation
- 1970-04-15 SE SE7005153A patent/SE371745B/xx unknown
- 1970-04-16 DK DK191170AA patent/DK127165B/da not_active IP Right Cessation
- 1970-04-17 GB GB08470/70A patent/GB1269185A/en not_active Expired
- 1970-04-17 FR FR7014066A patent/FR2045435A5/fr not_active Expired
- 1970-04-17 DE DE19702018588 patent/DE2018588A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL7005291A (nl) | 1971-06-08 |
| US3719655A (en) | 1973-03-06 |
| GB1269185A (en) | 1972-04-06 |
| CA918565A (en) | 1973-01-09 |
| NL154423B (nl) | 1977-09-15 |
| FR2045435A5 (nl) | 1971-02-26 |
| DE2018588A1 (de) | 1971-06-09 |
| DK127165B (da) | 1973-10-01 |